April 2011 USANs
| USAN | Research Code | Structure | Drug Type | Drug Class | Target |
| abexinostat, abexinostat hydrochloride | PCI-24781, S-78454, PCI-24781-01, S-78454-1, CRA-024781-HCl, CRA-024781-01 |  | synthetic small molecule | therapeutic | HDAC |
| anivamersen, anivamersen sodium | RB-007 |  | oligonucleotide | therapeutic | |
| brodalumab | AMG-827 | monoclonal antibody | therapeutic | IL-17RA | |
| cabozantinib, cabozantinib s-malate | XL-184, BMS-907351 |  | synthetic small molecule | therapeutic | MET RET VEGFR1 VEGFR2 VEGFR3 |
| calaspargase pegol | EZN-2285 |  | enzyme | therapeutic | - |
| cantuzumab ravtansine | huC242-DM4, IMGN-242 | monoclonal antibody conjugate | therapeutic | mucin CanAg | |
| cenderetide | CD-NP | peptide | therapeutic | NPRB | |
| crenolanib | ARO-002; CP-868,596 |  | synthetic small molecule | therapeutic | PDGFR |
| dabrafenib, dabrafenib mesylate | GSK-2118436A |  | synthetic small molecule | therapeutic | MEK |
| daclatasvir, daclatasvir dihydrochloride | BMS-790052 |  | synthetic small molecule | therapeutic | HCV NS5A |
| dacomitinib | PF-00299804-03 |  | synthetic small molecule | therapeutic | EGFR, HER2 |
| dasolampanel |  | synthetic small molecule | therapeutic | ||
| delanzomib | CEP-18770, CT-47098, NPH-007098 |  | synthetic small molecule | therapeutic | Proteosome |
| dolutegravir, dolutegravir sodium | GSK-1349572, S-349572, GSK-1349572A |  | synthetic small molecule | therapeutic | HIV-1 integrase |
| encaleret, encaleret sulfate |  | synthetic small molecule | therapeutic | ||
| fiboflapon, fiboflapon sodium | GSK-2190915A, GSK-2190915B |  | synthetic small molecule | therapeutic | FLAP |
| iofolastat I123 | MIP-1072 |  | synthetic small molecule | diagnostic | PSMA |
| irdabisant | CEP-26401 |  | synthetic small molecule | therapeutic | H3 |
| ixekizumab | LY-2439821 | monoclonal antibody | therapeutic | IL-17A | |
| levomilnacipran, levomilnacipran hydrochloride | F-2695 |  | synthetic small molecule | therapeutic | NET SET |
| lexibulin | CYT-997 |  | synthetic small molecule | therapeutic | |
| lumacaftor | VX-809, VRT-826809 |  | synthetic small molecule | therapeutic | |
| narnatumab | IMC-RON8, IMC RON-8, RON8 | monoclonal antibody | therapeutic | RON | |
| navarixin | SCH-527123 |  | synthetic small molecule | therapeutic | CXCR1, CXCR2 |
| olcorolimus | SAR-943, SAR-943N, SAR-943-NXA, SDZ-227-943N |  | natural product-derived small molecule | therapeutic | FKBP-12 |
| pegadricase | Uricase-PEG 20 |  | enzyme | therapeutic | - |
| peginterferon lambda-1a | PEG-IL-29, PEG-rIL-29 |  | protein | therapeutic | IL28RA |
| pegnivacogin, pegnivacogin sodium | RB-006 |  | oligonucleotide | therapeutic | |
| rucaparib, rucaparib phosphate | AG-14699, AG-014699, PF-01367338, AG-14447 |  | synthetic small molecule | therapeutic | PARP |
| sepantronium bromide | YM-155 |  | synthetic small molecule | therapeutic | BIRC5 |
| simeprevir | TMC-435; TMC-435350 |  | synthetic small molecule | therapeutic | HCV NS3/4A |
| sirukumab | CNTO-136 | monoclonal antibody | therapeutic | IL-6 | |
| suvorexant | MK-4305 |  | synthetic small molecule | therapeutic | OX1 OX2 |
| tabalumab | LY-2127399 | monoclonal antibody | therapeutic | BAFF | |
| technetium 99m tilmanocept | 1600 |  | synthetic small molecule | diagnostic | |
| tofacitinib | CP-690550, tasocitinib |  | synthetic small molecule | therapeutic | JAK3 |
As I get a few moments, I'll add the missing links and structures.... Sorry the structures are goofy.
Drug Type | Number |
synthetic small molecule | 31 |
natural product derived small molecule | 1 |
protein | 1 |
peptide | 1 |
monoclonal antibody | 7 |
enzyme | 2 |
oligonucleotide | 2 |
Cumulative total for 2011 | 45 |